Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Clinical Trials and Preclinical Infrastructure Asset Map - Life Sciences
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
282<br />
BRITISH COLUMBIA<br />
APPENDIX 9. Healthcare Research Centres (cont’d)<br />
RESEARCH CENTRE/ URL CONTACT DESCRIPTION<br />
Pharmaceutical<br />
Outcomes <strong>and</strong> Policy<br />
Innovations, Children’s<br />
<strong>and</strong> Women’s Health<br />
Centre of B.C.<br />
POPi<br />
www.popi.ubc.ca<br />
University of Victoria<br />
Pharmaceutical<br />
Outcomes <strong>and</strong> Policy<br />
Innovation<br />
POPI<br />
(no URL)<br />
UBC Centre for Health<br />
Services <strong>and</strong> Policy<br />
Research (CHSPR)<br />
www.chspr.ubc.ca<br />
The Pharmaceutical Outcomes<br />
Programme<br />
Children’s <strong>and</strong> Women’s Health Centre<br />
of B.C.<br />
E423-4480 Oak Street, Vancouver<br />
B.C., V6H 3V4<br />
Dr. Bruce Carleton, Director<br />
Tel: 604-875-3609<br />
bcarleton@popi.ubc.ca<br />
Public Administration/Human <strong>and</strong><br />
Social Development<br />
University of Victoria<br />
PO Box 1700 STN CSC<br />
Victoria B.C. V8W 2Y2<br />
Tel: 250-721-8066<br />
Fax: 250-721-8849<br />
Contact: Rebecca Warburton,<br />
Assistant Professor<br />
rnwarbur@uvic.ca<br />
201-2206 East Mall<br />
Vancouver B.C. V6T 1Z3<br />
Tel: 604-822–4969<br />
Fax: 604-822–5690<br />
enquire@chspr.ubc.ca<br />
Director, Maurice Barer<br />
Tel: 604-822-5992<br />
Contact: Vanessa Chu, Communications<br />
Specialist<br />
Tel: 604-822–6668<br />
vchu@chspr.ubc.ca<br />
This pediatric research unit operates out of the B.C. Children’s Hospital in association with the Faculty of Paediatrics at UBC. Its mission is to<br />
foster pharmaceutical policy innovation through proactive policy research, training <strong>and</strong> knowledge translation concerning the effectiveness,<br />
safety <strong>and</strong> cost management of prescription drugs. POPi has 3 general components: Drug Safety, Drug Effectiveness, Drug Policy.<br />
The goal of POPi’s Director, Dr. Bruce Carleton, is to make medication use more effective <strong>and</strong> safer for all patients, particularly children. His<br />
research focus is on the impact of drug therapy on human health <strong>and</strong> quality of life. He is particularly interested in developing better ways<br />
to evaluate the effectiveness of drugs, medication-use models designed to improve patient health, as well as practical surveillance systems<br />
to improve the safe use of medication.<br />
Pharmaceutical Outcomes <strong>and</strong> Policy Innovation (POPI) Research Unit studies drug effectiveness, safety <strong>and</strong> costs to provide<br />
decision makers with cost effective drug coverage strategies that produce the best health outcomes. Much of the work has a focus on<br />
pharmaceutical use by children <strong>and</strong> seniors, two populations particularly at risk for adverse drug reactions.<br />
POPI unit has access to the largest prescription database in Canada: B.C.’s PharmaNet system has captured all prescription drug purchases<br />
by B.C. residents since 1995, <strong>and</strong> can be linked to other databases with information on physician services, hospital care <strong>and</strong> vital statistics.<br />
POPI recommends improvements in clinical <strong>and</strong> public policy, including studying trends <strong>and</strong> regional variations in asthma care <strong>and</strong><br />
patient compliance with treatment; examining how to assess “real life” drug effectiveness in patients who may have multiple medical conditions,<br />
especially seniors; evaluating five provincial drug plans to determine optimal policies; evaluating the impact of academic detailing,<br />
or educational outreach, on drug prescribing across Canada to identify best practices in detailing programs; <strong>and</strong> identifying trends, safety<br />
concerns <strong>and</strong> research priorities regarding the dispensing of prescription medication to B.C. children.<br />
CHSPR undertakes policy relevant research <strong>and</strong> graduate training, <strong>and</strong> engages <strong>and</strong> informs health policy <strong>and</strong> issues that matter to<br />
Canadians.<br />
CHSPR Research is in scientific enquiry into population health <strong>and</strong> into ways in which health services can best be organized, funded <strong>and</strong><br />
delivered. Researchers <strong>and</strong> staff carry out a diverse program of research <strong>and</strong> development, delivering the tools <strong>and</strong> analyses needed to<br />
renew health care <strong>and</strong> improve the health of Canadians.<br />
CHSPR research interests are in the areas of:<br />
• Health <strong>and</strong> Health Care Use: Investigating population-wide patterns of health <strong>and</strong> health services use<br />
• Health Human Resources: Investigating the supply, distribution <strong>and</strong> service provision of physicians <strong>and</strong> nurses<br />
• Primary Health Care: Developing evidence-based frameworks <strong>and</strong> approaches to underst<strong>and</strong>ing primary health care systems<br />
• Pharmaceutical Policy: Studying the financing, delivery <strong>and</strong> use of prescription drugs<br />
• Workplace Health <strong>and</strong> Safety: Studying ways to improve workplace health <strong>and</strong> safety.